MASSACHUSETTS FINANCIAL SERVICES CO /MA/

Position in ACAD — Acadia Pharmaceuticals Inc

CIK 912938 Boston, MA

Position in ACAD

as of Jun 30, 2026 · filed Aug 3, 2026 Compact

Position Value

$21,642,505

-$1,058,777 QoQ

Shares Held

855,435

-16.1% QoQ

Ownership

0.496%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#32

of 354 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 99% Shared 1% None 0%

Healthcare · as of Jun 30, 2026

MASSACHUSETTS FINANCIAL SERVICES CO /MA/ holds $2,249,676,327 across 65 Biotechnology names. ACAD ranks #19 (1.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ASND	Ascendis Pharma A/S	1,875,301	$500,180,281
2	RVMD	Revolution Medicines, Inc.	2,012,317	$376,866,725
3	VRTX	Vertex Pharmaceuticals Inc / Ma	423,049	$210,141,127
4	TECH	BIO-TECHNE Corp	2,746,462	$194,037,538
5	SRRK	Scholar Rock Holding Corp	2,607,348	$143,404,140
6	LGND	Ligand Pharmaceuticals Inc	375,762	$118,774,610
7	ALNY	Alnylam Pharmaceuticals, Inc.	350,560	$105,529,075
8	BNTX	BioNTech SE	677,708	$63,060,728

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$21,642,505	855,435	-16.1%	Shares	Defined	2026-08-03
2026-03-31	$22,701,282	1,019,824	-4.9%	Shares	Defined	2026-05-14
2025-12-31	$28,646,020	1,072,483	-3.4%	Shares	Sole	2026-01-22
2025-09-30	$23,702,892	1,110,726	+1792.6%	Shares	Sole	2025-10-29
2025-06-30	$1,265,900	58,688	+1.3%	Shares	Sole	2025-08-08
2025-03-31	$962,765	57,963	-2.2%	Shares	Sole	2025-05-02
2024-12-31	$1,087,843	59,283	-2.9%	Shares	Sole	2025-02-12
2024-09-30	$938,964	61,051	-2.4%	Shares	Sole	2024-11-12
2024-06-30	$1,016,112	62,530	+3.5%	Shares	Sole	2024-08-09
2024-03-31	$1,117,350	60,430	-0.2%	Shares	Sole	2024-05-14
2023-12-31	$1,896,258	60,564	—	Shares	Sole	2024-02-08
No filing history on record for this holder in this stock.